DIA 48th Annual Meeting
Click here to go to the previous page
Meta-collaborations: A Call to Action
Track : Track 08: Regulatory Affairs and Submissions
Program Code: 208
Date: Tuesday, June 26, 2012
Time: 8:00 AM to 9:30 AM  EST
Location: Terrace 4
CHAIR (S):
 Craig Lipset, Pfizer Inc, United States
 Freda Lewis-Hall, Pfizer Inc, United States
PRESENTER (S):
Susan McCune, FDA
Margaret Anderson, FasterCures, United States
Kathy Hudson, National Institutes of Health, United States
 Peter Adamson, The Children's Hospital of Philadelphia, United States
 Freda Lewis-Hall, Pfizer Inc, United States
Description
What are the barriers that are keeping ideas from turning into action, and how can these barriers be broken to develop new models for innovation and collaboration? High-level thought leaders will address these questions and discuss how industry, academia, government, and patients, through meta-collaborations, can take drug discovery to the next level by creating opportunities for moving forward and coming up with solutions faster.

Learning Objectives:
Describe how barriers can be broken to develop new models for innovation and collaboration
Discuss how collaboration can take drug discovery forward.